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Atopic dermatitis (AD) is a chronic, recurrent inflamma-
tory skin condition that affects approximately 10–20% 
of children and 2–15% of adults in developed countries 
(1). In Singapore, the prevalence of AD among children 
and adolescents is 20.8% (2). Itchiness, the most common 
complaint, results in behavioural and social impairments 
among paediatric patients with AD, which in turn impacts 
on the wellbeing of caregivers, in particular family mem-
bers (3, 4). A sick child can markedly affect normal family 
life and the mental and social wellbeing of other family 
members (5). Their family members, specifically parents, 
may experience feelings of helplessness and stress as they 
struggle to treat their child’s symptoms, and this can lead 
to feelings of guilt as they feel they are failing in their duty 
to care for their offspring (6). In return, family quality of 
life (QoL) can greatly influence patient-related outcomes. 
Previous studies have demonstrated that paediatric AD can 
significantly affect family life; however, there is limited 
quantitative data on the factors influencing family life 
and functions (6). Therefore, the aim of this study was to 
gain in-depth insights into the family burden caused by 
paediatric AD, and to explore the social and clinical factors 
potentially impacting family life and function.
METHODS 
A cross-sectional survey was conducted during 2016 and 2017 
at 2 paediatric dermatology clinics in Singapore. Families were 
recruited if the patient was: (i) aged 0–16 years; and (ii) fulfilled 
the Hanifin & Rajka criteria for AD (7). 
The following information and instruments were included in 
the study: (i) the Dermatitis Family Impact (DFI) questionnaire, 
which assesses the impact of AD on family life and function (8); 
(ii) RAND-36, which assesses the physical and mental health 
of caregivers, whereby a lower score indicates poorer health or 
functioning (9); and (iii) Infants’ Dermatitis Quality of Life Index 
(IDQOL) in infants (0–3 years) and Children’s Dermatology Life 
Quality Index (CDLQI) in children (4–16 years) were merged 
into the health-related quality of life (HRQoL) score in order to 
evaluate AD-related QoL among paediatric patients; with this in-
strument, a higher score indicates a greater degree of impairment 
of QoL (10, 11). 
Eczema severity data was extracted from electronic medical 
records (EMR). For patients whose severity of symptoms was 
not explicitly reported in the EMR, symptoms and information 
on affected areas were extracted from EMR and assessed by 
the researcher (XX) using the Eczema Area and Severity Index 
(EASI) method (12).
Statistical analysis was carried out using Stata software package 
(version 14.2) (StataCorp, College Station, TX, USA). The Wil-
coxon rank-sum (or Mann–Whitney) test and the Kruskal–Wallis 
test were used to determine the statistical association between 
socio-demographic characteristics and DFI scores along with 
their subdomains. Subsequently, a negative binomial regres-
sion model was used to demonstrate the relationship between 
socio-demographic variables and DFI measures. Univariable and 
multivariable incidence rate ratios (IRR) were calculated and 
reported with 95% confidence intervals (CIs). A 2-sided p-value 
of < 0.05 was considered statistically significant, and the 95% CIs 
are presented below.
RESULTS 
In total, 559 families participated in the study. The ages 
of paediatric patients in the families ranged from 1 month 
to 16 years, with a mean age of 6.6 ± 4.6 years. Disease 
severity was mild in 56% of cases, moderate in 24%, and 
severe in 11%. Of the participants, 72% were Chinese, 
and Indian and Malay participants accounted for 16% and 
6%, respectively. A great majority of caregivers (81%) 
were educated to at least tertiary-level educational at-
tainment. The majority were employed (81%), and 19% 
were unemployed or retired. 
More than 94% of families reported that their family life 
and function were affected by their child’s AD (DFI > 0). 
The mean DFI score in affected families was 9.19 ± 7.28. 
Sleep disturbance, emotional distress and tiredness/
exhaustion were the subscales with the largest impacts. 
Significant differences among different disease severity 
groups was observed in terms of overall DFI score. In 9 
out of 10 subdomains, there were indications that families 
with children with more severe AD had poorer DFI scores 
than families with children with mild AD (Fig. 1). 
Univariate and multivariate models were used to analyse 
the factors influencing DFI; the results are shown in Table 
SI1. Families with younger children were less affected by 
their child’s AD (IRR 0.97, 95% CI 0.96, 0.99, p = 0.002). 
Disease duration and severity also significantly affect 
DFI: families with children with longer disease duration 
exhibited poorer DFI scores compared with families with 
children having AD for a shorter period (IRR 1.02, 95% 
CI 1.00, 1.04, p = 0.019). Families with children with mo-
derate and severe AD had poorer DFI scores than those 
with children with mild AD (moderate IRR 1.23, 95% CI 
1.09, 1.40, p = 0.001; severe IRR 1.26, 95% CI 1.06, 1.49, 
Factors Influencing Family Burden of Paediatric Patients with Atopic Dermatitis: A Cross-sectional Study
Xiaomeng XU1, Louise Sandra VAN GALEN1,2, Ram BAJPAI1,3, Mark Jean-Aan KOH4, Steven THNG5,6, Yik Weng YEW5,6, 
Krister JÄRBRINK1 and Josip CAR1*
1Centre for Population Health Sciences (CePHaS), Lee Kong Chian School of Medicine, Nanyang Technological University Singapore, Singapore, 
2Section of Acute Medicine, Department of Internal Medicine, VU University Medical Centre, The Netherlands, 3School of Primary Community 
and Social Care, Keele University, Staffordshire, UK, 4Dermatology Service, KK Women’s and Children’s Hospital, 5National Skin Centre, 
Singapore, and 6Skin Research Institute of Singapore, 8A Biomedical Grove, Immunos, Singapore. *E-mail: josip.car@ntu.edu.sg
Accepted Mar 12, 2020; Epub ahead of print Mar 17, 2020
1https://www.medicaljournals.se/acta/content/abstract/10.2340/00015555-3458
A
ct
aD
V
A
ct
aD
V
A
d
v
a
n
c
e
s 
in
 d
e
rm
a
to
lo
g
y
 a
n
d
 v
e
n
e
re
o
lo
g
y
A
c
ta
 D
e
rm
a
to
-V
e
n
e
re
o
lo
g
ic
a
Short communication2/2
www.medicaljournals.se/acta
p = 0.008). As for the caregivers’ QoL, both the mental and 
physical health of caregivers can affect DFI. Better mental 
and physical health among caregivers is associated with a 
better DFI (physical health IRR 0.99, 95% CI 0.98, 0.99, 
p < 0.001; mental health IRR 0.99, 95% CI 0.99, 0.99, 
p < 0.001). A family whose child has a poorer HRQoL had a 
poorer DFI score (IRR 1.04, 95% CI 1.03, 1.05, p < 0.001). 
DISCUSSION 
Of the families included in this study 94% reported their 
DFI to be affected by their child’s AD, with the most 
commonly affected domains being sleep disturbance, 
emotional distress, and tiredness/exhaustion. In addition, 
the severity of the child’s AD was found to be significantly 
associated with DFI and its subdomains, indicating that 
severe AD causes more severe impairment of family 
functioning. Univariate and multivariate models showed 
that the patient’s age and disease severity influence DFI. 
This study also found that the self-reported QoL in pa-
ediatric patients and the mental and physical health of the 
caregivers contribute to impaired family life and function. 
The impact of childhood AD on DFI can be substantial. It 
has been reported that the QoL of families with children 
with AD are more impaired than that of families with 
psoriasis patients, and is comparable to that of families 
with congenital ichthyosis patients (13, 14).
Family support plays a significant role in the treatment 
of AD, and this study provides a unique perspective into 
the family burden of paediatric patients with AD. Follo-
wing a review of previous works (3, 6), statistical models 
were used to identify the influencing factors on family 
life, which could generate meaningful data for informing 
treatment decisions in clinical practice. Our sample size is 
large enough to be generalized to Singapore and to other 
multi-ethnic countries. However, there are also a number 
of limitations to this study that merit attention. First, the 
family impact data is based on parents’ self-reporting, and 
might not represent all family members’ points of view. 
Secondly, there is no healthy control group included in 
this study, which precludes the calculation of comparisons 
with healthy families. 
In conclusion, this study was conduc-
ted in order to provide a more in-depth 
insight into the impact of paediatric AD 
on families, in order to improve overall 
family QoL, treatment of AD should not 
be limited to the patients; rather, the ap-
proach should be broadened to involve 
family members.
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Fig. 1. Association between mean score of reported Dermatitis Family Impact subdomains 
and children’s disease severity. X-axis: Dermatitis Family Impact (DFI) subdomains; y-axis: 
mean score of dermatitis family impact. *Significant differences in dermatitis family impact 
between different severity groups. ~missing data: n = 46.
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